PROVIDER PROFILE · NPI 1437485281

Philip Mckay

PRACTICEAMERICASHEALTH PLAN, INC.See all providers at this practice →

Physician AssistantVentura, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,816

Beneficiaries

—

Total drug cost

$264K

Distinct drugs

Brand share

29.5%

Top prescribed drugs

Atorvastatin Calcium185 claims

Losartan Potassium129 claims

Amlodipine Besylate113 claims

Metformin Hcl83 claims

Dapagliflozin Propanediol80 claims

QUALITY · MIPS · 2024

Final MIPS score

86.0

Quality

64.5

Cost

72.2

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.46%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$870

Payment records

By payment type

Food and Beverage$870

REFERRAL NETWORK

Where Philip Mckay's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 7 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
CLINICAS DEL CAMINO REAL INC	145	712
Udit Kondal Family Practice · Corona, NY	18	62
DIGNITY HEALTH	15	35

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · San Diego, CA	95	294
CLINICAS DEL CAMINO REAL INC	87	266
Udit Kondal Family Practice · Corona, NY	20	70
DIGNITY HEALTH	16	37
Yogender Garg Ophthalmology · Oxnard, CA	14	45
Syd Bakshandeh Internal Medicine · Ventura, CA	13	58
Peter Soliman Family Practice · Ventura, CA	11	43

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history